The financing will support the company working capital needs to ensure ample supply of active pharmaceutical ingredients for essential generic medicine production.
This project demonstrates ADB continued efforts to enhance health outcomes in Vietnam by encouraging the development and use of local generic medicines, he added.
Imexpharm was established in 1977 and initially incorporated in 1983 as the Dong Thap Pharmaceutical Union. The firm was transformed from a state-owned enterprise into a joint-stock company and renamed Imexpharm Corporation, and its shares were listed on the Ho Chi Minh Stock Exchange in December 2006.
As of September 30, Imexpharm had 1,252 employees, total assets of 2.07 trillion VND (89.66 million USD), and six pharmaceutical manufacturing facilities.